ATS Stat

HomeATS Stat ▶ Stat Oct. 6, 2021
Stat Oct. 6, 2021

CDC Awards Cooperative Agreement to the CMSS and Specialty Society Partners to Improve Adult Immunization Rates for High-Risk Adults

The Centers for Disease Control and Prevention  recently awarded a cooperative agreement to the Council of Medical Specialty Societies (CMSS), including the ATS as one of seven collaborating specialty societies, to improve vaccination among high-risk adults. CMSS is a coalition of 45 specialty societies, representing more than 800,000 physicians across healthcare.

This five-year cooperative agreement includes $22 million in funding in the first year (with an estimated $55.5 million over five years) to support increased COVID-19, influenza, and routine vaccinations in high-risk adults with chronic medical conditions, including patients with chronic obstructive pulmonary disease, asthma, diabetes, heart disease, cancer, and chronic kidney disease, as well as older adults and staff in occupational health settings.

Read more. 


Upcoming Events

Industry Innovations, “TSLP in Asthma: Examining the Evidence"

When: 6:30 p.m. ET, Oct. 12, 2021
Register now.

Sponsored by Amgen/AstraZeneca.       


Industry Innovations, “Nontuberculous Mycobacterial Lung Disease (NTM-LD): Individualizing Treatment Goals and Strategies – An Innovative Whiteboard View”

When: 6:30 p.m. ET, Oct. 20, 2021
Register now.

Sponsored by an educational grant from Insmed.  


The Children’s Interstitial and Diffuse Lung Disease Research Network (chILD-RN) Special Interest Group Virtual Meeting 2021

When: 12 p.m. ET, Oct. 29, 2021
Register now!


Now Accepting Nominations for Elizabeth A. Rich, MD Award

For more than two decades, the Elizabeth A. Rich, MD Award has been presented to an outstanding woman in the American Thoracic Society who has made significant contributions in the fields of pulmonary, critical care, and sleep medicine. We are now accepting nominations for the 2022 recipient! The recipient will be recognized at the Women’s Forum at the ATS 2022 International Conference, at which she will be invited to speak.

Nominate a colleague today!


CME Opportunities!

Emerging Treatment Strategies for the Management of Patients with Chronic Cough – Cases

In this second component of a two-part educational curriculum, pulmonary experts will discuss the prevalence, unmet clinical needs, and impact of chronic cough in patients who do not find relief from recommended management strategies. Full CME information available here!

When: 2 p.m. ET, Oct. 9, 2021
Register now!

Supported by an educational grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.


EGPA: Facilitating Prompt Recognition and Optimal Treatment

In, "EGPA: Facilitating Prompt Recognition and Optimal Treatment," a one-hour activity led by three EGPA experts, will address the most current information on the diagnosis, treatment initiation, and long-term monitoring of this rare eosinophilic disorder. Full CME information is available here.

Expires: Nov. 13, 2021
Register and get started now!

Supported by an educational grant from GlaxoSmithKline.


PF-ILD, IPF, and CTD-ILD Primers Available Now!

The ATS ILD Education Center was developed by a panel of ILD experts in who believe improving patient outcomes begins with an accurate, early diagnosis. This educational site features tools and resources for practicing pulmonologists, general practitioners, radiologists, pathologists, and rheumatologists, designed to help improve patient outcomes with an accurate and early diagnosis.

Check out our newest resources:

Supported by Boehringer Ingelheim Pharmaceuticals, Inc